GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Total Long-Term Liabilities

AP Biosciences (ROCO:6945) Total Long-Term Liabilities : NT$64.71 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. AP Biosciences's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was NT$64.71 Mil.

AP Biosciences Total Long-Term Liabilities Historical Data

The historical data trend for AP Biosciences's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Total Long-Term Liabilities Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
- - - 75.78 64.71

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Liabilities Get a 7-Day Free Trial - 81.27 75.78 70.27 64.71

AP Biosciences Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

AP Biosciences Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Total Long-Term Liabilities
Comparable Companies
ROCO:06891 ROCO:3176 ROCO:6808 ROCO:4178 ROCO:1777 TPE:6838 TPE:6794 ROCO:8279 ROCO:6733 ROCO:6634 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines